ACS Infectious Diseases, a journal published by the American Chemical Society, publishes research that advances the field of infectious disease research through the publication of impactful work, which emphasizes the basic sciences and lays foundations for clinical work to improve human health.
The scope of the journal encompasses all aspects of chemistry relating to infectious diseases research including research on pathogens, host-pathogen interactions, therapeutics, diagnostics, vaccines, drug-delivery systems, and other biomedical technology development pertaining to infectious diseases. We are continuing to seek submissions in areas not yet extensively covered in the journal, such as viral and fungal infections, drug delivery, and diagnostics.
Our journal issues feature diverse research topics publishes in the form of Articles, Letters, Reviews, Perspectives, and Viewpoints. To highlight emerging research areas, current topics relevant to the infectious disease field, or research in specific geographic areas, ACS Infectious Diseases also publishes thematic Virtual and Special Issues, often in collaboration with its sister journals such as ACS Chemical Neuroscience, ACS Chemical Biology, ACS Medicinal Chemistry Letters, and Journal of Medicinal Chemistry.
Prospective authors are welcome to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research by emailing the Editorial Office: email@example.com
The journal is currently welcoming submissions for upcoming Special Issues on the following research topics. You are encouraged to consider submitting your manuscript, should your research falls into one of the following categories:
- CNS-Related Pathogens: Submissions due Sept. 1, 2019
- Infectious Disease Research in China (open to first and/or corresponding authors located in China): Submissions due Sept. 30, 2019
- Chemical Microbiology: Submissions due Nov. 1, 2019
- Antibiotics: Submissions due Jan. 15, 2020
The ACS brand recognition will ensure high visibility for your research and our rapid, thorough review process will disseminate your work without any delays. There are no publication charges, though the additional ACS AuthorChoice license gives you the option to make your published work open access upon publication, if desired.
On behalf of ACS Infectious Diseases’ Editor-in-Chief, Courtney C. Aldrich, the Editorial team and the Editorial Advisory Board, all of whom are also prominent leaders in their respective fields: Thank you in advance for your kind consideration of ACS Infectious Diseases as the destination for your next manuscript!